Literature DB >> 16785864

Risk factors and characteristics of ocular complications, and efficacy of autologous serum tears after haematopoietic progenitor cell transplantation.

S C Leite1, R S de Castro, M Alves, D A Cunha, M E P Correa, L A da Silveira, A C Vigorito, C A de Souza, E M Rocha.   

Abstract

The objective of the study was to evaluate the frequency and clinical characteristics of ocular complications and their risk factors, as well as autologous serum tears (AST) for the treatment of dry eye in these patients. Data from the files of 124 patients who had undergone allogeneic haematopoietic progenitor cell transplantation (HPCT) were evaluated. In addition, 33 HPCT patients were examined and their data were compared with controls. Analysis of tears and AST was performed. Dry eye manifestation occurred in 32% of patients and was positively correlated with age over 27 years (P = 0.05), peripheral blood progenitor cell transplant (P = 0.002), chronic graft-versus-host disease (P = 0.0027), and chronic or acute myeloid leukaemia (P = 0.001). Dry mouth and Schirmer test < 5 mm were predictive factors for dry eye in HPCT patients (P = 0.002 and odds ratio 3.9 and P = 0.007, odds ratio = 5.9, respectively). Microbiological analysis revealed that six of 11 AST samples were contaminated after 30 days of use. The present study supports the role of potential risk factors for ocular complications and key elements to detect alterations in the tear film from HPCT patients. In addition, AST contamination must be considered after longer periods of use.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16785864     DOI: 10.1038/sj.bmt.1705426

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  11 in total

1.  Ocular surface analysis in hematological patients before and after allogeneic hematopoietic stem cell transplantation: implication for daily clinical practice.

Authors:  G Giannaccare; F Bonifazi; M Sessa; E Dan; M Arpinati; M Fresina; G Bandini; M Cavo; P Versura; E C Campos
Journal:  Eye (Lond)       Date:  2017-05-19       Impact factor: 3.775

2.  Onset of ocular graft-versus-host disease symptoms after allogeneic hematopoietic stem cell transplantation.

Authors:  Hasanain Shikari; Francisco Amparo; Ujwala Saboo; Reza Dana
Journal:  Cornea       Date:  2015-03       Impact factor: 2.651

Review 3.  Ocular Graft-versus-Host Disease after Hematopoietic Cell Transplantation: Expert Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Transplant Complications Working Party of the European Society of Blood and Marrow Transplantation.

Authors:  Yoshihiro Inamoto; Nuria Valdés-Sanz; Yoko Ogawa; Monica Alves; Luigi Berchicci; John Galvin; Hildegard Greinix; Gregory A Hale; Biljana Horn; Debra Kelly; Hien Liu; Scott Rowley; Helene Schoemans; Ami Shah; Maria Teresa Lupo Stanghellini; Vaibhav Agrawal; Ibrahim Ahmed; Asim Ali; Neel Bhatt; Michael Byrne; Saurabh Chhabra; Zachariah DeFilipp; Kristina Fahnehjelm; Nosha Farhadfar; Erich Horn; Catherine Lee; Sunita Nathan; Olaf Penack; Pinki Prasad; Seth Rotz; Alicia Rovó; Jean Yared; Steven Pavletic; Grzegorz W Basak; Minoo Battiwalla; Rafael Duarte; Bipin N Savani; Mary E D Flowers; Bronwen E Shaw; Igor Petriček
Journal:  Biol Blood Marrow Transplant       Date:  2018-11-24       Impact factor: 5.742

4.  Dry Eye Disease Incidence Associated with Chronic Graft-Host Disease: Nonconcurrent Cohort Study (An American Ophthalmological Society Thesis).

Authors:  Shahzad I Mian; Paola De la Parra-Colín; Rafael De Melo-Franco; Christopher Johnson; Tonatiuh Barrientos-Gutierrez
Journal:  Trans Am Ophthalmol Soc       Date:  2015-09

5.  Influence of insulin treatment on the lacrimal gland and ocular surface of diabetic rats.

Authors:  Carolina Maria Módulo; Angélica Gobbi Jorge; Ana Carolina Dias; Alexandre Martins Braz; Rubens Bertazolli-Filho; Alceu A Jordão; J Sérgio Marchini; Eduardo M Rocha
Journal:  Endocrine       Date:  2009-06-24       Impact factor: 3.633

6.  Ocular graft-versus-host disease after hematopoietic cell transplantation: Expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT.

Authors:  Yoshihiro Inamoto; Nuria Valdés-Sanz; Igor Petriček; Yoko Ogawa; Monica Alves; Luigi Berchicci; John Galvin; Hildegard Greinix; Gregory A Hale; Biljana Horn; Debra Kelly; Hien Liu; Scott Rowley; Helene Schoemans; Ami Shah; Maria Teresa Lupo Stanghellini; Vaibhav Agrawal; Ibrahim Ahmed; Asim Ali; Neel Bhatt; Michael Byrne; Saurabh Chhabra; Zack DeFilipp; Kristina Fahnehjelm; Nosha Farhadfar; Erich Horn; Catherine Lee; Sunita Nathan; Olaf Penack; Pinki Prasad; Seth Rotz; Alicia Rovó; Jean Yared; Steven Pavletic; Grzegorz W Basak; Minoo Battiwalla; Rafael Duarte; Bipin N Savani; Mary E D Flowers; Bronwen E Shaw
Journal:  Bone Marrow Transplant       Date:  2018-12-07       Impact factor: 5.483

7.  Limbitis secondary to autologous serum eye drops in a patient with atopic keratoconjunctivitis.

Authors:  Jeffrey David Welder; Pejman Bakhtiari; Ali R Djalilian
Journal:  Case Rep Ophthalmol Med       Date:  2011-12-21

8.  Evaluation of the efficacy of 50% autologous serum eye drops in different ocular surface pathologies.

Authors:  Francesco Semeraro; Eliana Forbice; Osvaldo Braga; Alessandro Bova; Attilio Di Salvatore; Claudio Azzolini
Journal:  Biomed Res Int       Date:  2014-07-22       Impact factor: 3.411

9.  Is Sjögren's syndrome dry eye similar to dry eye caused by other etiologies? Discriminating different diseases by dry eye tests.

Authors:  Denny Marcos Garcia; Fabiola Reis de Oliveira; Carolina Maria Módulo; Jacqueline Faustino; Amanda Pires Barbosa; Monica Alves; Eduardo Melani Rocha
Journal:  PLoS One       Date:  2018-12-03       Impact factor: 3.240

10.  Ocular graft versus host disease in allogenic haematopoetic stem cell transplantation in a tertiary care centre in India.

Authors:  Rehan Khan; Sridevi Nair; Tullika Seth; Pravas Mishra; Manoranjan Mahapatra; Tushar Agarwal; Radhika Tandon; Murugesan Vanathi
Journal:  Indian J Med Res       Date:  2015-11       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.